The Last Word on JAK Inhibitor Safety and 1133 Study (1.28.2022)

Save

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com Check out RheumNow.Live

Believing Is Doing (1.21.2022)

Save

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. These reports are about better outcomes in Lupus; Less Gout flares with T2T and the power of belief.

The Overpricing Of Drugs (1.14.2022)

Save

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com RheumNow.Live is March 19, 20th in Dallas, TX

2021 Rheumatology Year in Review (1.7.2022)

Save

Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.

Best of 2021 -Jack of All Subspecialties (12.31.2021)

Save

New to RheumNow? Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields.

My Podcast Gift (12.24.2021)

Save

Merry Christmas and Happy Holidays from RheumNow. Dr. Jack Cush tells his podcast story - the genesis, keys to success and recommendations on how to get into podcasting - for teaching, practice, fun or influence.

Indications Awaiting (12.17.21)

Save

Dr Jack Cush reviews the latest news, journal reports, regulatory approvals, plus 3 new cases from rheumatologists.

Women Leaders in Rheumatology

Save

A moderated panel of prominent female rheumatologists will discuss the challenges and successes in clinical practice and research that they encountered during the COVID-19 pandemic.

T2T Debate - Prologue with Dr. Marty Bergman

Save

Drs. Jack Cush and Martin Bergman gather to review the topic of treat-to-target (T2T) management in rheumatology. Both will debate the pro's and con's of the T2T strategy at the upcoming RWCS meeting on Feb. 17, 2022. You can register and learn more about the meeting at: https://r-w-c-s.com/2022/

RheumNow Podcast - Telemedicine Upside (12.3.21)

Save

Dr. Jack Cush discusses the evolution and future of telemedicine in rheumatology with the telemedicine guru - Dr. Alvin Wells

RheumNow Podcast - 60.40.20 Interview with Dr. Ed Keystone

Save

Dr. Jack Cush interviews Professor Edward Keystone, MD (from the University of Toronto) on the origins and science behind the 60/40/20 benchmark and outcomes in rheumatoid arthritis.

Spondyloarthritis Panel Discussion- ACR21 Meeting

Save

Panelists: Drs. Antoni Chan, Robert Chao, Rachel Tate, Sheila Reyes and Akhil Sood.